Connect with us

Technology

AI in Healthcare Market to Reach USD 505.6 Billion by 2033, Driven by Rapid Adoption of AI-Powered Clinical Solutions and Digital Healthcare Transformation

Published

on

Global AI in Healthcare Market Expected to Expand at 38.90% CAGR from 2026 to 2033 as Healthcare Systems Embrace Predictive Analytics, Precision Medicine, and Automation

SAN FRANCISCO, June 24, 2026 /PRNewswire/ — The global artificial intelligence (AI) in healthcare market is projected to witness significant growth, reaching USD 505.59 billion by 2033, according to a new report by Grand View Research, Inc. The market was estimated at USD 36.7 billion in 2025 and is anticipated to grow from USD 50.7 billion in 2026 to USD 505.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 38.90% during the forecast period from 2026 to 2033.

The increasing demand for advanced healthcare technologies, rising adoption of artificial intelligence-driven clinical decision support systems, growing healthcare data volumes, and the need for improved patient outcomes are accelerating the integration of AI across healthcare ecosystems. AI technologies are enabling healthcare providers to transition from traditional reactive models toward predictive, personalized, and preventive healthcare approaches.

AI Transforming Healthcare Delivery Through Advanced Analytics and Automation

Artificial intelligence is emerging as a transformative technology within the healthcare industry by enabling faster diagnosis, improved treatment planning, operational efficiency, and enhanced patient engagement. AI-powered solutions are being increasingly deployed across medical imaging, clinical decision support, drug discovery, patient monitoring, administrative automation, and personalized medicine applications.

Healthcare organizations are leveraging machine learning, natural language processing, computer vision, and deep learning technologies to analyze complex medical datasets, identify disease patterns, and support healthcare professionals with actionable insights. The ability of AI systems to process large-scale clinical information is helping improve diagnostic accuracy and optimize healthcare workflows.

Clinical decision support systems powered by AI are becoming increasingly important as healthcare providers seek real-time insights to enhance decision-making and improve patient care outcomes. These solutions assist physicians by analyzing patient information, identifying potential risks, and supporting evidence-based treatment strategies.

Get Free Sample of this Research Report for more latest industry insights

Rising Healthcare Data Volumes and Digital Transformation Fuel Market Growth

The rapid digitization of healthcare infrastructure is one of the major factors contributing to the expansion of the AI in healthcare market. The increasing adoption of electronic health records (EHRs), connected medical devices, wearable technologies, and remote patient monitoring solutions is generating substantial amounts of healthcare data.

AI platforms are helping organizations convert this data into meaningful clinical and operational intelligence. Healthcare providers are increasingly adopting AI solutions to improve resource utilization, streamline workflows, reduce operational costs, and deliver more personalized patient experiences.

The growing prevalence of chronic diseases, increasing healthcare expenditure, and rising demand for efficient healthcare delivery models are further supporting market growth. AI-driven solutions are enabling healthcare systems to improve early disease detection, enhance treatment outcomes, and support continuous patient monitoring.

Software Segment and AI-Based Solutions Drive Healthcare Innovation

The AI in healthcare market is segmented by component, application, technology, end use, and region. The market includes hardware, software, and services components, with AI software solutions playing a critical role in enabling advanced analytics, automation, and decision-support capabilities.

AI applications across clinical trials, cybersecurity, medical imaging analysis, robotic-assisted procedures, drug discovery, and healthcare management are expanding rapidly as organizations invest in intelligent healthcare infrastructure.

The integration of AI into clinical research is also creating new opportunities by improving patient recruitment, accelerating data analysis, and supporting faster development of medical innovations. AI technologies are helping pharmaceutical and biotechnology companies analyze complex biological data and enhance research efficiency.

Growing Adoption of AI in Precision Medicine and Personalized Healthcare

The increasing focus on personalized medicine is creating new growth opportunities for AI adoption in healthcare. AI algorithms can analyze patient-specific information, including medical history, genetic data, and clinical indicators, to support individualized treatment strategies.

Precision healthcare initiatives are increasingly using AI to identify disease risks, predict treatment responses, and improve therapeutic outcomes. The technology is supporting advancements in areas such as oncology, cardiology, neurology, and diagnostics by enabling more accurate and timely medical interventions.

AI-powered healthcare platforms are also contributing to remote care models by supporting virtual healthcare services, remote monitoring, and patient engagement solutions. These capabilities are becoming increasingly important as healthcare systems worldwide focus on improving accessibility and efficiency.

North America Leads AI Healthcare Adoption While Asia Pacific Presents Growth Opportunities

North America continues to represent a significant region for AI healthcare adoption due to advanced healthcare infrastructure, strong technology investments, and increasing implementation of digital health solutions. The region benefits from the presence of leading technology companies, healthcare organizations, and research institutions focused on AI innovation.

Meanwhile, Asia Pacific is expected to witness strong growth opportunities due to increasing healthcare digitalization, rising investments in healthcare technology, improving healthcare infrastructure, and growing demand for advanced medical solutions.

Countries across emerging markets are increasingly exploring AI applications to improve healthcare accessibility, address workforce challenges, and enhance diagnostic capabilities.

Browse more Research Reports in Healthcare IT Industry

Competitive Landscape and Industry Outlook

The global AI in healthcare market includes several prominent technology and healthcare companies focusing on innovation, strategic partnerships, and development of advanced AI platforms. Key companies profiled in the market include Microsoft, IBM, NVIDIA Corporation, Intel Corporation, GE Healthcare, Google, Medtronic, Oracle, Medidata, Merck, and IQVIA.

Market participants are investing in research and development activities, AI-enabled healthcare platforms, cloud-based solutions, and strategic collaborations to strengthen their market position.

As healthcare organizations continue adopting artificial intelligence technologies, AI is expected to play a central role in improving clinical decision-making, operational efficiency, and patient outcomes globally.

Grand View Research Report Coverage

The Grand View Research report provides an in-depth analysis of the artificial intelligence in healthcare market, including market size, growth trends, competitive landscape, segment analysis, and regional insights. The report covers historical data from 2021 to 2025 and provides forecasts for the period from 2026 to 2033.

To learn more about growth opportunities in the AI In Healthcare Market, access the full report from Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Browse GVR’s U.S. Healthcare Facility Mapping & Intelligence Platform

Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
Blog – https://globalindustryherald.com/

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ai-in-healthcare-market-to-reach-usd-505-6-billion-by-2033–driven-by-rapid-adoption-of-ai-powered-clinical-solutions-and-digital-healthcare-transformation-302808113.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Hyperscale Data Delays Investor Conference Call to June 26, 2026

Published

on

By

LAS VEGAS, June 24, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), today announced that it has delayed its previously announced conference call from today, June 24, 2026, to Friday, June 26, 2026, at 1:30 PM PT. The Company is seeking to provide stockholders and other interested parties with additional time to register.

As previously announced, please use the link provided below to register for the conference call. Stockholders and interested parties who have already registered do not need to register again. https://us06web.zoom.us/webinar/register/WN_12LNAeAqSBu2qYbtp_OBxg

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it mines digital assets and offers colocation and hosting services for the emerging AI ecosystems and other industries. Hyperscale Data’s other wholly owned subsidiary, Ault Capital Group, Inc. (“ACG”), is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in the second quarter of 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-delays-investor-conference-call-to-june-26-2026-302809842.html

SOURCE Hyperscale Data Inc.

Continue Reading

Technology

HelloNation Explains How to Choose an Orthodontist With Insights From Orthodontic Expert Dr. Judith Okun

Published

on

By

The article outlines key factors for selecting the right provider and understanding treatment approaches in White Plains.

WHITE PLAINS, N.Y., June 24, 2026 /PRNewswire/ — What should patients look for when deciding on the right orthodontist for their needs? HelloNation has published an article that provides clear guidance on choosing an orthodontist, featuring insights from Orthodontic Expert Dr. Judith Okun of Okun Orthodontics in Rye Brook, near White Plains, New York.

The HelloNation article explains that selecting an orthodontist near White Plains, NY, involves more than convenience alone. While location plays a role, especially for ongoing visits, patients are encouraged to consider qualifications, communication style, and the range of orthodontic treatment options available. A thoughtful approach can support better long-term oral health and a more comfortable experience throughout treatment.

One of the most important factors discussed is choosing a board-certified orthodontist. The article notes that board certification reflects additional training and a commitment to maintaining high standards of care. A board-certified orthodontist is more likely to stay current with evolving techniques and best practices, which can directly benefit patient outcomes. Experience is also emphasized, as a Westchester County orthodontist who has handled a wide variety of cases is better prepared to address both routine and complex needs.

The article highlights the importance of the orthodontist consultation as a key step in the decision-making process. During an orthodontic consultation, patients should expect a clear explanation of their condition and a review of possible orthodontic treatment options. These may include traditional braces, clear aligners, or other corrective methods. The article emphasizes that understanding these orthodontic treatment options helps patients make informed decisions aligned with their goals.

Communication is another critical component outlined in the article. A strong orthodontist near White Plains, NY, will take time during the orthodontic consultation to explain each option in simple terms. This level of clarity helps patients feel more confident and prepared as they begin treatment. The article also notes that open dialogue encourages patients to ask questions and better understand the process.

The structure of care delivery is another factor patients are encouraged to consider. The article explains that some practices offer private treatment rooms for orthodontics, while others use shared treatment spaces. Private treatment room orthodontics may provide a more personalized and comfortable experience for some individuals. Patients are also advised to ask whether the orthodontist will personally perform adjustments or if certain tasks are handled by staff, as this can affect expectations during treatment.

Convenience remains an important practical element. Choosing an orthodontist near your home, such as near White Plains, NY, allows patients to attend appointments more consistently, which supports steady progress. The article notes that factors such as office hours, scheduling flexibility, and accessibility all contribute to a smoother experience. A Westchester County orthodontist who offers convenient scheduling can help reduce missed visits and delays.

The article also emphasizes the value of having access to a variety of orthodontic treatment options. A Westchester County orthodontist who is familiar with multiple techniques can tailor care to each patient’s specific needs. This flexibility supports both cosmetic goals and long-term oral health outcomes. Understanding how to choose an orthodontist involves evaluating whether a provider can offer this range of care.

In addition, the article explains that trust plays a central role in the decision. Patients who understand how to choose an orthodontist are more likely to feel confident throughout the process. By focusing on credentials such as working with a board-certified orthodontist, evaluating communication during the orthodontist consultation, and considering practical factors like location and the availability of a private treatment room, individuals can make informed decisions.

The article concludes that choosing an orthodontist near White Plains, NY requires careful consideration of both professional qualifications and personal comfort. A balanced approach helps ensure that treatment is effective, consistent, and aligned with patient expectations.

How to Choose the Right Orthodontist Near White Plains, NY, features insights from Dr. Judith Okun, Orthodontic Expert at Okun Orthodontics in Rye Brook, near White Plains, New York, on HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

www.hellonation.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-explains-how-to-choose-an-orthodontist-with-insights-from-orthodontic-expert-dr-judith-okun-302809867.html

SOURCE HelloNation

Continue Reading

Technology

Praecipio Joins the Claude Partner Network to Accelerate Atlassian Delivery

Published

on

By

AUSTIN, Texas, June 24, 2026 /PRNewswire/ – Praecipio today announced it is a Select partner in the Claude Partner Network Services track. Joining the Claude Partner Network formalizes how Praecipio uses Claude, powered by Anthropic, to accelerate the Atlassian work enterprises already rely on: ITSM and ESM implementations, cloud migrations, and managed services. Additionally, Praecipio has launched its own Enterprise AI implementation service lines leveraging Claude.

Praecipio is a pure-play Atlassian Platinum Solution Partner. Along with helping organizations implement AI powered services within their own operations, Praecipio applies Claude as an intelligence layer within its existing service lines, so its consultants move faster through initial analysis work and spend their effort on decisions that affect a client’s bottom line.

” The enterprises we work with aren’t just adopting AI, they’re rethinking how they operate.” said Sneha Crews, SVP of AI and Technology Strategy at Praecipio. “What drew us to Claude is that it meets the real complexity of those environments, and we’ve proven that from the inside. Praecipio rebuilt its own delivery model around Claude before we took it to clients. That’s the transformation expertise we’re bringing to every engagement; a team that’s already on the other side of the change they’re trying to make. ”

At the center of the practice is the Praecipio Intelligence Gateway, which analyzes an Atlassian environment and delivers a comprehensive assessment in under 30 minutes. Built using Claude on Praecipio’s proprietary Intelligence Framework, it gives enterprises the clarity to move forward with confidence, whether they are planning a move to Cloud or getting more out of the environment they already have. Claude reads and reasons across thousands of data points — configurations, project structures, user patterns, and application dependencies — synthesizing findings that would take a team of consultants daysweeks to compile manually. The result is a prioritized, plain-language roadmap that tells decision-makers exactly what they have, what needs to change, and why.

The Gateway reflects how Praecipio applies Claude across its service lines. For data center customers, it assesses migration readiness, surfacing script complexity, app compatibility, integration dependencies, and data volume, then delivers a business case alongside the technical findings. For customers already on Cloud, it runs a health check that identifies configuration sprawl, governance gaps, process inefficiencies, and quick wins, with prioritized recommendations tied to measurable outcomes.

Crucially, the firm pairs automation with people. Every report can be reviewed and contextualized by a Praecipio specialist. Customers are not getting a black-box output, they are getting a Claude-powered starting point for a real conversation with people who have done this before. The principle runs through the firm’s positioning: Claude and validated by Praecipio’s human Atlassian experts.

From Praecipio CEO, Chris Lewis: “We’ve built our reputation on being the Atlassian partner enterprises count on for their most complex challenges. Joining the Claude Partner Network lets us bring that same standard of excellence to AI, and it creates something unique in the market: an Atlassian-native AI practice that is supported by Claude and validated by people who have done this work for two decades. Praecipio brings together its Atlassian expertise and Claude, to create a genuinely differentiated offering.”

In managed services, Praecipio applies the same Claude-based framework to surface anomalies, identify optimization opportunities, and act on them. What the firm learns in each engagement improves the next, giving clients the benefit of Praecipio’s full practice.

About Praecipio

Praecipio is a pure-play Atlassian Platinum Solution Partner, headquartered in Austin, Texas, and an eight-time Atlassian Partner of the Year. It is a Select partner in the Claude Partner Network Services Track.

View original content to download multimedia:https://www.prnewswire.com/news-releases/praecipio-joins-the-claude-partner-network-to-accelerate-atlassian-delivery-302809882.html

SOURCE Praecipio Consulting LLC

Continue Reading

Trending